These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 33129689)
21. Identification and functional analysis of a defect in the human ALG9 gene: definition of congenital disorder of glycosylation type IL. Frank CG; Grubenmann CE; Eyaid W; Berger EG; Aebi M; Hennet T Am J Hum Genet; 2004 Jul; 75(1):146-50. PubMed ID: 15148656 [TBL] [Abstract][Full Text] [Related]
22. Expanding the phenotype, genotype and biochemical knowledge of ALG3-CDG. Alsharhan H; Ng BG; Daniel EJP; Friedman J; Pivnick EK; Al-Hashem A; Faqeih EA; Liu P; Engelhardt NM; Keller KN; Chen J; Mazzeo PA; ; Rosenfeld JA; Bamshad MJ; Nickerson DA; Raymond KM; Freeze HH; He M; Edmondson AC; Lam C J Inherit Metab Dis; 2021 Jul; 44(4):987-1000. PubMed ID: 33583022 [TBL] [Abstract][Full Text] [Related]
23. Congenital disorder of glycosylation type Id (CDG Id): phenotypic, biochemical and molecular characterization of a new patient. Rimella-Le-Huu A; Henry H; Kern I; Hanquinet S; Roulet-Perez E; Newman CJ; Superti-Furga A; Bonafé L; Ballhausen D J Inherit Metab Dis; 2008 Dec; 31 Suppl 2():S381-6. PubMed ID: 18679822 [TBL] [Abstract][Full Text] [Related]
24. Central nervous involvement is common in PGM1-CDG. Radenkovic S; Witters P; Morava E Mol Genet Metab; 2018 Nov; 125(3):200-204. PubMed ID: 30262252 [TBL] [Abstract][Full Text] [Related]
26. A novel homozygous mutation in the human ALG12 gene results in an aberrant profile of oligomannose N-glycans in patient's serum. Ziburová J; Nemčovič M; Šesták S; Bellová J; Pakanová Z; Siváková B; Šalingová A; Šebová C; Ostrožlíková M; Lekka DE; Brucknerová J; Brucknerová I; Skokňová M; Mc Cullough A; Hrčková G; Hlavatá A; Bzdúch V; Mucha J; Baráth P Am J Med Genet A; 2021 Nov; 185(11):3494-3501. PubMed ID: 34467644 [TBL] [Abstract][Full Text] [Related]
27. Bosch-Boonstra-Schaaf optic atrophy syndrome (BBSOAS) initially diagnosed as ALG6-CDG: Functional evidence for benignity of the ALG6 c.391T>C (p.Tyr131His) variant and further expanding the BBSOAS phenotype. Starosta RT; Tarnowski J; Vairo FPE; Raymond K; Preston G; Morava E Eur J Med Genet; 2020 Jul; 63(7):103941. PubMed ID: 32407885 [TBL] [Abstract][Full Text] [Related]
28. Identification and characterization of a new variation in Zhao P; Hu Y; Hu J; Li C; Huang Y; Zhang L; Luo S; Zhu H; Jiang J; He X Front Genet; 2023; 14():930692. PubMed ID: 37152991 [No Abstract] [Full Text] [Related]
29. ALG11-CDG: novel variant and review of the literature. Erdal AE; Ceylan AC; Gücüyener K; Öktem RM; Kıreker Köylü O; Kasapkara ÇS J Pediatr Endocrinol Metab; 2023 Apr; 36(4):409-413. PubMed ID: 36843332 [TBL] [Abstract][Full Text] [Related]
34. Congenital disorder of glycosylation type Ij (CDG-Ij, DPAGT1-CDG): extending the clinical and molecular spectrum of a rare disease. Würde AE; Reunert J; Rust S; Hertzberg C; Haverkämper S; Nürnberg G; Nürnberg P; Lehle L; Rossi R; Marquardt T Mol Genet Metab; 2012 Apr; 105(4):634-41. PubMed ID: 22304930 [TBL] [Abstract][Full Text] [Related]
35. Expanding the NGLY1 deficiency phenotype: Case report of an atypical patient. Nolan DK; Pastore MT; McBride KL Eur J Med Genet; 2022 Aug; 65(8):104558. PubMed ID: 35779835 [TBL] [Abstract][Full Text] [Related]
36. A compound heterozygous mutation in DPAGT1 results in a congenital disorder of glycosylation with a relatively mild phenotype. Iqbal Z; Shahzad M; Vissers LE; van Scherpenzeel M; Gilissen C; Razzaq A; Zahoor MY; Khan SN; Kleefstra T; Veltman JA; de Brouwer AP; Lefeber DJ; van Bokhoven H; Riazuddin S Eur J Hum Genet; 2013 Aug; 21(8):844-9. PubMed ID: 23249953 [TBL] [Abstract][Full Text] [Related]
37. Congenital disorders of glycosylation with emphasis on cerebellar involvement. Barone R; Fiumara A; Jaeken J Semin Neurol; 2014 Jul; 34(3):357-66. PubMed ID: 25192513 [TBL] [Abstract][Full Text] [Related]
38. [CDG (congenital disorders of glycosylation). Differential hereditary ataxia in adulthood diagnosis]. Bubel S; Peters V; Klein C; Hackler R; Schaefer JR; Hagenah J; Hoffmann GF; Vieregge P Nervenarzt; 2002 Aug; 73(8):754-60. PubMed ID: 12242963 [TBL] [Abstract][Full Text] [Related]
39. Congenital disorders of glycosylation and infantile epilepsy. Lee HF; Chi CS Epilepsy Behav; 2023 May; 142():109214. PubMed ID: 37086590 [TBL] [Abstract][Full Text] [Related]
40. Immune dysfunction in MGAT2-CDG: A clinical report and review of the literature. Poskanzer SA; Schultz MJ; Turgeon CT; Vidal-Folch N; Liedtke K; Oglesbee D; Gavrilov DK; Tortorelli S; Matern D; Rinaldo P; Bennett JT; Thies JM; Chang IJ; Beck AE; Raymond K; Allenspach EJ; Lam C Am J Med Genet A; 2021 Jan; 185(1):213-218. PubMed ID: 33044030 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]